Phase II clinical trial of 4'-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in the treatment of advanced non-Hodgkin's lymphomas. [electronic resource]
- Haematologica
- 35-8 p. digital
Publication Type: Journal Article
0390-6078
Adult Aminoacridines--therapeutic use Amsacrine Antineoplastic Agents--therapeutic use Drug Evaluation Female Humans Leukopenia--chemically induced Lymphoma--drug therapy Male Middle Aged Thrombocytopenia--chemically induced